JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB172580

Anti-53BP1 antibody

Be the first to review this product! Submit a review

|

(28 Publications)

Rabbit Polyclonal 53BP1 antibody. Suitable for WB, IP, Flow Cyt, IHC-P, ICC/IF and reacts with Mouse, Rat, Human samples. Cited in 28 publications. Immunogen corresponding to Synthetic Peptide within Human TP53BP1 aa 1400 to C-terminus.

View Alternative Names

TP53-binding protein 1, 53BP1, p53-binding protein 1, p53BP1, TP53BP1

8 Images
Immunocytochemistry/ Immunofluorescence - Anti-53BP1 antibody (AB172580)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-53BP1 antibody (AB172580)

Immunocytochemistry/Immunofluorescence analysis of U2OS cells labelling 53BP1 with ab172580 at 1 : 1000. Cells were fixed with PFA and permeabilized with methanol for 2 minutes. Cells were incubated with the primary anitbody overnight at room temperature.

Flow Cytometry - Anti-53BP1 antibody (AB172580)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-53BP1 antibody (AB172580)

Flow Cytometry analysis of HeLa cells labelling 53BP1 with ab172580 at 1 : 800. Cells were fixed with 1% PFA. Cells were incuabted with the primary antibody overnight at 4°C.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-53BP1 antibody (AB172580)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-53BP1 antibody (AB172580)

Immunohistochemistry (formalin/PFA-fixed paraffin-embedded) analysis of Human linfoid tissue labelling 53BP1 with ab172580 at 1 : 1000. Antigen retrieval was by microwave boiling for 7 minutes in 10mM TrisHCl, pH9.

Immunocytochemistry/ Immunofluorescence - Anti-53BP1 antibody (AB172580)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-53BP1 antibody (AB172580)

Immunocytochemistry/Immunofluorescence analysis of U2OS cells labelling 53BP1 with ab172580 at 1 : 1000. Cells were fixed with PFA and permeabilized with methanol for 2 minutes. Cells were incubated with the primary anitbody overnight at room temperature. Top - 53BP1, Middle - DAPI, Bottom - Merge.

Immunoprecipitation - Anti-53BP1 antibody (AB172580)
  • IP

Supplier Data

Immunoprecipitation - Anti-53BP1 antibody (AB172580)

Immunoprecipitation analysis of U2OS cells labelling 53BP1 with ab172580. Protein A beads were crosslinked to the serum.

All lanes:

Immunoprecipitation - Anti-53BP1 antibody (ab172580)

Predicted band size: 214 kDa

false

Western blot - Anti-53BP1 antibody (AB172580)
  • WB

Supplier Data

Western blot - Anti-53BP1 antibody (AB172580)

All lanes:

Western blot - Anti-53BP1 antibody (ab172580)

Lane 1:

U2OS (Control si)

Lane 2:

U2OS (53BP1 si)

Lane 3:

NIH 3T3 cell lysate at 40 µg

Lane 4:

PC12 cell lysate at 40 µg

Predicted band size: 214 kDa

false

Immunocytochemistry/ Immunofluorescence - Anti-53BP1 antibody (AB172580)
  • ICC/IF

CiteAb

Immunocytochemistry/ Immunofluorescence - Anti-53BP1 antibody (AB172580)

Immunocytochemistry-immunofluorescence using Anti-53BP1 antibody, ab172580. Publication image from Ferreira-Gonzalez, S. et al., 2018, Nat Commun, 29523787. Legend direct from paper.

Paracrine senescence in the model is TGFβ-dependent. Mouse data is presented at day 2 after final tamoxifen administration (N = 6 per group). (Left) K19Cre-positive mice without tamoxifen injection. (Center) K19Cre-negative mice after tamoxifen injection. (Right) K19Cre-positive mice after tamoxifen injection. a p53 (red, indicative of primary senescence events in the cholangiocytes) and p21 (green) co-localize in the bile ducts. However, p21-positive p53-negative cholangiocytes were observed. b p21 (green) co-localizes with HNF4α-positive hepatocytes (red). c p27 (green) colocalizes with p53-positive cholangiocytes (red). p27 is expressed in cholangiocytes and hepatocytes in a paracrine manner. d p27 (green) co-localizes with HNF4α-positive hepatocytes (red). e Markers of senescence (such as 53BP1, H2A.X and DCR2, in red) are expressed in cholangiocytes and liver parenchyma, while expression of p53 (green) is restricted to the cholangiocytes. Single channels for this figure are provided in Supplementary Fig. 8a. Scale bars = 50 µm. f qRT-PCR analysis of Tgfb1 in the isolated bile ducts of Cre− +TM (N = 5) and induced Cre+ +TM (N = 6) K19-Mdm2flox/floxtdTomLSL mice day 2 after induction. *** denotes p < 0.005 (Mean ± SEM). Mann−Whitney test. g Analysis of common SASP’s factors by qRT-PCR (from left to right, Tgfbr1, Tgfbr2, Nfkb, Il1a and Il6). * denotes p < 0.05, ** p < 0.01 (Mean ± SEM). Mann−Whitney test. h Western blot of phospho-NF-κB-p65 and pSmad2/3. Each band represents the bile ducts isolated from one mouse. Blots are companied by at least one marker position (molecular weights MW, in kDa). Far right, western blot densitometry quantification (normalized to bActin control) show increased expression of NF-κBp-65 and pSmad2/3 after induction of the model. * denotes p < 0.05 (Mean ± SEM). Mann−Whitney test. i qRT-PCR of Nfkb in hepatocytes isolated from Cre− and Cre+ K19-Mdm2flox/floxtdTomLSL mice at day 2 after last tamoxifen administration (N = 5-6 per group). ** denotes p < 0.01 (Mean ± SEM). Mann−Whitney test

Western blot - Anti-53BP1 antibody (AB172580)
  • WB

CiteAb

Western blot - Anti-53BP1 antibody (AB172580)

53BP1 western blot using anti-53BP1 antibody ab172580. Publication image and figure legend from Warmerdam, D. O., Alonso-de Vega, I., et al., 2020, EMBO Rep, PubMed 31782600.

ab172580 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab172580 please see the product overview.

PHF6 controls classical NHEJA, BU2OS cells expressing GFP-PHF6 and mCherry-NBS1 were locally irradiated in the absence and presence of ATM and ATR inhibitors. Shown is the recruitment of GFP-PHF6 (A) or mCherry-NBS1 (B) to laser-induced breaks in time. At least 30 cells were analyzed in three individual experiments, and error bars represent the SD.CU2OS-DR cells containing the I-SceI HR reporter were transfected with the indicated siRNA oligos and I-SceI. 48 h later, the cells were fixed and analyzed by flow cytometry. Represented is the relative repair efficiency as compared to the Luciferase control. Error bars represent the SEM of three independent experiments. Statistical significance was determined using a two-tailed, unpaired t-test (**p < 0.01, ***p < 0.001, ****p < 0.0001).DU2OS cells depleted of PHF6 with three different siRNA oligonucleotides and U2OS WT and PHF6 knockout cells were lysed and analyzed using Western blot with the indicated antibodies.EU2OS WT and PHF6 knockout cells transfected with siRNA oligos against luciferase or XRCC4 were lysed and analyzed using Western blot with the indicated antibodies. The remaining PHF6 signal in the PHF6 KO sample is likely due to a cross reaction at similar height as PHF6 (also see Fig EV3C).F, GDistribution of the deletion sizes (F) or the extent of microhomology for the category simple deletions (G) obtained from independently obtained I-SceI repair events (described in Fig 4E) in the indicated samples.

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, IHC-P, ICC/IF, Flow Cyt, IP

applications

Immunogen

Synthetic Peptide within Human TP53BP1 aa 1400 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q12888

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-polyclonal-isotype-control-chip-grade-ab171870'>ab171870</a> - Rabbit polyclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/1000", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
Constituents: Water
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

53BP1 also known as p53-binding protein 1 is a protein that plays an important role in DNA damage response. The 53BP1 protein has a molecular weight of approximately 213 kDa. It is a nuclear protein and it mainly expresses in cells during the DNA damage repair processes. Researchers commonly utilize immunofluorescence and anti-53BP1 antibodies to detect its presence especially for studying DNA repair mechanisms. 53BP1 proves important for maintenance of genomic stability.
Biological function summary

As a DNA damage response mediator 53BP1 functions to recognize and bind to sites of double-strand breaks in DNA promoting non-homologous end joining (NHEJ). This protein is a component of a larger protein complex that recruits factors necessary for DNA repair. Its interaction with DNA lesions also involves chromatin remodeling aiming to facilitate successful repair of the DNA. 53BP1 works in concert with other proteins such as H2AX and MDC1.

Pathways

Researchers observe 53BP1 in processes such as the DNA damage checkpoint and repair pathways. This protein significantly contributes to the pathways involved in maintaining cell cycle checkpoints. It interacts with proteins like ATM and BRCA1 coordinating the cellular response to DNA damage and ensuring that genomic integrity checks occur properly before cell cycle progression continues. These interactions place 53BP1 at a pivotal position in decision-making between repair pathways.

Researchers often focus on 53BP1's involvement in cancer development and therapy resistance due to its role in DNA repair. Alterations or deficiencies in 53BP1 levels can contribute to increased susceptibility to tumor development affecting processes like breast cancer and ovarian cancer through its relationship with BRCA1. The improper function of 53BP1 in DNA repair pathways may lead to an accumulation of genetic mutations driving tumorigenesis and impacting the efficacy of certain cancer treatments.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed : 12364621, PubMed : 17190600, PubMed : 21144835, PubMed : 22553214, PubMed : 23333306, PubMed : 27153538, PubMed : 28241136, PubMed : 31135337, PubMed : 37696958). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed : 22553214, PubMed : 23333306, PubMed : 23727112, PubMed : 27153538, PubMed : 31135337). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed : 28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed : 17190600, PubMed : 23760478, PubMed : 27153538, PubMed : 28241136). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed : 23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed : 23727112).
See full target information TP53BP1

Publications (28)

Recent publications for all applications. Explore the full list and refine your search

Translational oncology 49:102092 PubMed39153367

2024

Radiosensitizing effects of CDK4/6 inhibitors in hormone receptor-positive and HER2-negative breast cancer mediated downregulation of DNA repair mechanism and NF-κB-signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Wen-Chi Yang,Ming-Feng Wei,Yi-Hsuan Lee,Chiun-Sheng Huang,Sung-Hsin Kuo

Nucleic acids research 52:6360-6375 PubMed38682589

2024

DNA-PK participates in pre-rRNA biogenesis independent of DNA double-strand break repair.

Applications

Unspecified application

Species

Unspecified reactive species

Peng Li,Xiaochen Gai,Qilin Li,Qianqian Yang,Xiaochun Yu

Frontiers in oncology 14:1323313 PubMed38380364

2024

Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Sathya Neelature Sriramareddy,Majeed Jamakhani,Léa Vilanova,Hélène Brossel,Bernard Staumont,Malik Hamaidia

Developmental dynamics : an official publication of the American Association of Anatomists 253:467-489 PubMed37850827

2023

Maternal exposure to hyperbaric oxygen at the preimplantation stages increases apoptosis and ectopic Cdx2 expression and decreases Oct4 expression in mouse blastocysts via Nrf2-Notch1 upregulation and Nf2 downregulation.

Applications

ICC/IF

Species

Mouse

Yu-Ming Li,Yu Lang Chung,Yung-Fu Wu,Chien-Kuo Wang,Chieh-Min Chen,Yi-Hui Chen

Cell death discovery 9:200 PubMed37386001

2023

Biallelic FBXW7 knockout induces AKAP8-mediated DNA damage in neighbouring wildtype cells.

Applications

Unspecified application

Species

Unspecified reactive species

Dedrick Kok Hong Chan,Amit Mandal,Svenja Hester,Zhanru Yu,Geoff Stuart Higgins,Benedikt Mathias Kessler,Roman Fischer,Simon James Alexander Buczacki

Nature methods 20:706-713 PubMed37024653

2023

Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq.

Applications

IF

Species

Human

Roger S Zou,Yang Liu,Oscar E Reyes Gaido,Maximilian F Konig,Brian J Mog,Leo L Shen,Franklin Aviles-Vazquez,Alberto Marin-Gonzalez,Taekjip Ha

Chemico-biological interactions 370:110330 PubMed36563735

2022

Synergistic effect of naphthalenediimide and squaraine ligand targeting G-quadruplex DNA in cancer cells.

Applications

IF

Species

Human

Xueyu Hao,Chunjie Li,Hongyu Zhao,Wanli Wei,Chengbin Li,Rizhe Jin,Chuanqing Kang,Lianxun Gao

Science translational medicine 14:eabj4375 PubMed36475903

2022

Senolytic treatment preserves biliary regenerative capacity lost through cellular senescence during cold storage.

Applications

IHC

Species

Mouse

Sofia Ferreira-Gonzalez,Tak Yung Man,Hannah Esser,Rhona Aird,Alastair M Kilpatrick,Daniel Rodrigo-Torres,Nicholas Younger,Lara Campana,Victoria L Gadd,Benjamin Dwyer,Niya Aleksieva,Luke Boulter,Mark T Macmillan,Yinmiao Wang,Katie J Mylonas,David A Ferenbach,Timothy J Kendall,Wei-Yu Lu,Juan Carlos Acosta,Dominic Kurian,Stephen O'Neill,Gabriel C Oniscu,Jesus M Banales,Paul J Krimpenfort,Stuart J Forbes

Oxidative medicine and cellular longevity 2022:7957255 PubMed36092168

2022

Atorvastatin Attenuates Radiotherapy-Induced Intestinal Damage through Activation of Autophagy and Antioxidant Effects.

Applications

Unspecified application

Species

Unspecified reactive species

Ming-Feng Wei,Ching-Hsueh Cheng,Shu-Yu Wen,Jui-Chueh Lin,Yu-Hsuan Chen,Chun-Wei Wang,Yi-Hsuan Lee,Sung-Hsin Kuo

Cells 11: PubMed36010569

2022

USP29 Deubiquitinates SETD8 and Regulates DNA Damage-Induced H4K20 Monomethylation and 53BP1 Focus Formation.

Applications

WB, IF

Species

Human, Human

Yeray Hernández-Reyes,María Cristina Paz-Cabrera,Raimundo Freire,Veronique A J Smits
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com